Compare SLQT & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLQT | QSI |
|---|---|---|
| Founded | 1999 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.6M | 161.8M |
| IPO Year | 2020 | N/A |
| Metric | SLQT | QSI |
|---|---|---|
| Price | $0.60 | $0.74 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $2.88 | $1.00 |
| AVG Volume (30 Days) | 1.2M | ★ 3.1M |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 105.00 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $1,526,594,000.00 | N/A |
| Revenue This Year | $11.42 | N/A |
| Revenue Next Year | $7.76 | $618.07 |
| P/E Ratio | $60.48 | ★ N/A |
| Revenue Growth | ★ 15.50 | N/A |
| 52 Week Low | $0.56 | $0.72 |
| 52 Week High | $3.73 | $3.10 |
| Indicator | SLQT | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 33.72 | 34.20 |
| Support Level | N/A | N/A |
| Resistance Level | $0.94 | $1.11 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 32.63 | 12.24 |
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.